Celgene Corp (NASDAQ:CELG)
| CAPS Rating |
|
|---|---|
| Open | $71.97 |
| Previous Close | $72.00 |
| Daily Range | $71.51 - $72.29 |
| 52-Week Range | $50.28 - $75.11 |
| Market Cap | $32.91B |
| P/E Ratio | 30.20 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 2,971,526 |
| Average Daily Volume | 0 |
CELG
VS S&P 500 (SPY)
How do you think CELG will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CELG Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CELG News and Commentary
- 3 Biotechnology Stocks for Short-Term Traders – NASDAQ
- Blood Disease Drug Dacogen Gets Thumbs Down for Cancer Use – Minyanville
- Has Amgen Become the Perfect Stock? – The Motley Fool
- Which Big Biotech Is the Best Bet? – The Motley Fool
- Celgene Meets on the Top Line, Misses Where It Counts – The Motley Fool
- 2 Biotech Acquisitions in 1 Day! Let's Throw a Party – The Motley Fool
- Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies – Minyanville
- UPDATE: Celgene To Buy Avila For Up To $925 Million; 4Q Net Up 96% – SmartMoney
- Celgene Misses Narrowly in 4Q - Analyst Blog – NASDAQ
- Celgene To Buy Avila For $350 Million Cash; 4Q Net Rises 96% – SmartMoney
- The Zacks Analyst Blog Highlights: Celgene, Advanced Micro Devices, Seagate, Western Digital and Int – NASDAQ
- Earnings Preview: Celgene - Analyst Blog – NASDAQ
- Stocks That Are Raising the Bar – The Motley Fool
- EARNINGS PREVIEW: US Biotechs' 4Q Focus On Pipelines, Deals – SmartMoney
- Celgene Continues to Outperform - Analyst Blog – NASDAQ
- Zacks Bull and Bear of the Day Highlights: Celgene, Darden Restaurants, Starwood Hotels & Resorts Wo – NASDAQ
- Celgene Corp. (CELG) - Bull of the Day – NASDAQ
- The Zacks Analyst Blog Highlights: Celgene, Nissan Motor, Toyota Motor, Honda Motor and Daimler - Pr – NASDAQ
- Celgene's Preliminary Earnings Impress - Analyst Blog – NASDAQ
- Celgene Predicts Better-Than-Expected 2012 Profit – SmartMoney
RSS Headlines
Fool UK
